ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

プロパセタモール

Propacetamol

HCID 68865
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
66532-85-2
標準SMILES
CCN(CC)CC(=O)Oc1ccc(NC(C)=O)cc1
InChIKey
QTGAJCQTLIRCFL-UHFFFAOYSA-N
分子式
C14H20N2O3
平均分子量
264.32 g/mol
単同位体質量
264.1473925

概要

Propacetamol is an alpha-amino acid ester.

名称と識別子

優先名称
Propacetamol
IUPAC
(4-acetamidophenyl) 2-(diethylamino)acetate
現地名
プロパセタモール
英語名
Propacetamol
分子式
C14H20N2O3
分子量
264.32

名称と別名

Propacetamol66532-85-2PropacetamolumDTXSID30578005CHW4JMR82DTXCID70315894-acetamidophenyl 2-(diethylamino)acetateRefChem:176249N02BE05N, N-diethylglycine 4'-hydroxyacetanilide ester266-390-1(4-acetamidophenyl) 2-(diethylamino)acetate
名称をさらに表示
プロパセタモールN,N-ジエチルグリシン4-(アセチルアミノ)フェニル(ジエチルアミノ)酢酸4-(アセチルアミノ)フェニル4-アセトアミドフェニル 2-(ジエチルアミノ)アセタートPropacetamoPro-DafalganPropacatemolPropacetamol USP/EP/BP4-Acetamidophenyl N,N-diethylglycinate4-acetamidophenyl N,N-diethylaminoacetateN,N-Diethylglycine 4-(acetylamino)phenyl ester(Diethylamino)acetic acid 4-(acetylamino)phenyl
Propacetamol [INN]Glycine, N,N-diethyl-, 4-(acetylamino)phenyl esterPropacetamol (INN)Propacetamolum [Latin]EINECS 266-390-1Propacetamol [INN:BAN]UNII-5CHW4JMR82Propacetamol (Standard)

データベース識別子

CAS
66532-85-2
PubChem CID
68865
DTXSID
DTXSID3057800
ChEMBL
CHEMBL1851805
ChEBI
CHEBI:135089
UNII
5CHW4JMR82
EC Number
266-390-1
Nikkaji
J32.504J

物性

構造計算による物性

XLogP
1.1
極性表面積
58.6 Ų
水素結合供与体数
1
水素結合受容体数
4
回転可能結合数
7
重原子数
19
形式電荷
0
複雑度
295

実験および物理化学的性質

Chemical ClassesOther Uses -> Pharmaceuticals
DrugsPharmaceuticals -> Listed in ZINC15
SolubilitySoluble
Boiling Point434.5ºC at 760 mmHg

物理化学的性質

融点
55 · 55-57 °C
沸点
434.5 · 434.5±30.0 °C(Predicted)
比重(密度)
1.132 · 1.132±0.06 g/cm3(Predicted)
貯蔵温度
-20 °C · Store at -20°C
溶解性
2 O · H2O : 100 mg/mL (378.33 mM; Need ultrasonic)
酸解離定数(Pka)
14.2 · 14.20±0.70(Predicted)
外見
Solid
色
White to off-white
CAS データベース
66532 · 66532-85-2(CAS DataBase Reference)

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

危険有害性情報

Hazards SummaryAllergic contact dermatitis reported in nurses (contact and airborne dermatitis); [Kanerva, p. 1829]

毒性情報

Adverse EffectsSkin Sensitizer - An agent that can induce an allergic reaction in the skin.
Drug Induced Liver Injury · 4 件

Drug-Induced Liver Injury Severity and Toxicity (DILIst)

Propacetamol

DILI Positive

DOI:10.1016/j.drudis.2019.09.022

化学と産業

薬理情報

ATC Code · 2 件

N - Nervous system

QN - Nervous system

Protein BindingPropacetamol is very rapidly converted into paracetamol and this later component tends to present a very negligible binding to plasma proteins.
Pharmacodynamics · 1 件

Propacetamol is hydrolyzed to paracetamol and then it presents a weak inhibition of COX-1 and COX-2 which is translated into a low anti-inflammatory activity. Therefore, in high inflammatory conditions, such as rheumatoid arthritis, these agents show limited in vivo suppression of inflammation and platelet activity. The formation of N-arachidonoylphenolamine, donates paracetamol with analgesic and antipyretic properties.

Mechanism of Action · 1 件

As propacetamol is a prodrug, its mechanism of action is directly linked to the activity of paracetamol. The mechanism of action of paracetamol is described by the inhibition of prostaglandin synthesis. This inhibition is attained by inhibition of COX-1 and COX-2 in an environment where arachidonic acid and peroxides are kept low. It is considered that paracetamol presents a very complex mechanism of action involving effects in the peripheral system, described by direct COX inhibition; the central system, characterized by inhibition of COX, serotonergic descending neuronal pathway, L-arginine/NO pathway and cannabinoid system; and a redox mechanism. In the brain and spinal cord, paracetamol can combine with arachidonic acid to form N-arachidonoylphenolamine. This metabolite is an activator of capsaicin receptor (TRPV1) and cannabinoid CB1.

Biological Half-LifeThe half-life of propacetamol is of 3.6 h.
Metabolism/Metabolites · 1 件

After administration, propacetamol is completely converted by plasma esterases into N, N-diethylglycine and paracetamol. The latest is the active metabolite. It is reported that the active metabolite of propacetamol can be transformed to N-acetil-p-benzoquinone imine by CYP2E1 which is a hepatotoxic metabolite.

関連反応

1 件
反応記録を作成
HRID 2311000 の反応式
HRID 2311000生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
MeSH Pharmacological Classification · 2 件

Compounds capable of relieving pain without the loss of CONSCIOUSNESS.

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Absorption, Distribution and Excretion · 4 件

The bioavailability of 2g of propacetamol is similar to the bioavailability found in 1 g of intravenous paracetamol. Peak plasma concentration is obtained as and from the end of infusion. Pharmacokinetic analysis with intravenous propacetamol showed a significantly higher and earlier maximum plasma concentration than orally administered paracetamol. The Cmax, Tmax and AUC are 12.72 mcg/ml, 0.25 h and 25.5 mcg.h/ml. After infusion with propacetamol, significant concentrations of paracetamol are observed in cerebrospinal fluid.

The metabolites of propacetamol are mainly excreted in the urine. From the elimination rate, 90% of the administered dose is excreted in 24 hours mainly as glucuronide and sulfate conjugates. Less than 5% is eliminated as unchanged paracetamol.

The volume of distribution of propacetamol is 1.29 l/kg.

The clearance rate of propacetamol is 0.28 l.h/kg.

用途と製造

UsesThis pro-drug of acetaminophen is administered intravenously. [Kanerva, p. 1829]
応用分野 · 2 件

説明Propacetamol is the prodrug of paracetamol (acetaminophen), used for intravenous administration. It results from eombination of paracetamol and diethylglycine. Causes contact dermatitis and airborne dermatitis in nurses. Allergenic properties are due to the N,N' -diethylglycine moiety, and not to the paracetamol moiety.

使用Propacetamol hydrochloride is a water-soluble prodrug for intravenous administration resulting in the liberation of paracetamol.

上流・下流製品情報

上流原料

Phenyl esterクロロ酢酸ヨウ化カリウム炭酸カリウムジエチルアミンクロロアセチルクロリドアニリン